Expression Pattern and Possible Clinical Significance of CD81 In Myeloid Leukemia
Launched by ASSIUT UNIVERSITY ยท
Trial Information
Current as of October 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a protein called CD81 and how it might affect certain types of blood cancer called myeloid leukemia, including acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Researchers want to find out if having high levels of CD81 in leukemia cells is connected to a more serious form of the disease, how well patients respond to treatment, or how long patients live after diagnosis. Understanding this could help doctors predict how the disease will progress and possibly guide better treatment choices in the future.
The study is looking for people who have recently been diagnosed with myeloid leukemia, especially AML. If you take part, your bone marrow or blood samples will be collected during your regular tests, so no extra procedures are needed. The study is open to adults of all genders between the ages of 65 and 74. Right now, the trial is not yet recruiting participants. This research is important because it may help improve care for people with myeloid leukemia by tailoring treatments based on the presence of CD81.
Gender
ALL
Eligibility criteria
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported